Testing a 12-Week ECCCLORE Therapy Program for Adults with Addiction and Trauma Issues

What this Trial Is About

Researchers are studying the feasibility and acceptability of a 12-week adaptation of the ECCCLORE program for patients facing both addiction and trauma-related problems, including complex posttraumatic stress disorder cPTSD. This condition involves ongoing difficulties with emotion regulation, identity, and relationships after prolonged trauma exposure and is often linked to more severe addiction and behaviors like impulsivity and hostility. The study aims to address these intertwined issues to improve patient quality of life. The intervention being tested is the ECCCLORE program, a cognitive behavioral therapy originally developed for borderline personality disorder, now shortened to 12 weeks for this study. It involves weekly 2-hour group sessions with up to 10 participants, combined with 30-minute individual sessions after each group meeting. Sessions include discussions of the previous week, explanations of key concepts, and practices, plus support for home practice implementation. The program incorporates elements from Acceptance and Commitment Therapy and focuses on emotional regulation, distress tolerance, and interpersonal skills. Participants will be assessed at baseline and after 12 and 24 weeks for trauma, addiction, impulsivity, hostile attribution bias, aggressivity, flexibility, and depression through patient-reported measures. Primary outcomes focus on program feasibility, dropout rates, and acceptability of home practice by week 12. The study excludes certain psychiatric conditions and requires participants to be able to read and write French, with informed consent and health insurance coverage. Participation involves regular therapy sessions and follow-up assessments over the study period.

Adaptation of the ECCCLORE Program for Patients With Addictive and Traumatic Problems